The CARE™ Congress on Biosimilars – Central
was a great success!
This regional meeting served as a platform for health care providers from Central Canada to meet, discuss, and share opinions with regards to how biosimilars are going to impact Canadian healthcare.
Presentations reviewed the basic science, clinical trial data for biosimilars, and considered the current and potential impact biosimilars will have on the Canadian landscape. Regional perspectives were provided from different stakeholders, including: specialists, advocacy groups, allied health care representatives, legal, payers, and Health Canada.
Thank you to all attendees, speakers, panelists and sponsors who participated in the event!
Dr. Vipul Jairath
University of Western Ontario
Date: Friday, October 27th, 2017
Time: 12:00 – 4:30 pm
Location: Delta London Armouries
325 Dundas St, London, ON N6B 1T9
Scientific Review – Rob Laister, PhD (Princess Margaret Cancer Centre)
Review of Biosimilars Clinical Data – Dr. Vipul Jairath (Western University)
Advocacy Group Perspective – Eric Thomson, BA, MA (Crohn’s & Colitis Canada)
Allied Health Care Perspective – Usha Chauhan, NP (McMaster University),
Carolyn Whiskin, RPh (Charlton Health Inc.)
How to Integrate Biosimilars into Clinical Practice – Dr. Janet Pope (Western University)
Payers Perspective – Joe Whitney, BA, MA (Manulife), Sherry O’Quinn, BScPharm (MORSE Consulting)
Health Canada Perspective – Jian Wang, MD, PhD (Health Canada – Clinical Evaluation Division)
Legal & Ethical Perspective – Karen Townsend, PhD (Torys LLP)